Literature DB >> 21976045

Reversal of dopamine inhibition of dopaminergic neurons of the ventral tegmental area is mediated by protein kinase C.

Sudarat Nimitvilai1, Devinder S Arora, Mark S Brodie.   

Abstract

Adaptation of putative dopaminergic (pDA) neurons in the ventral tegmental area (VTA) to drugs of abuse may alter information processing related to reward and reinforcement and is an important factor in the development of addiction. We have demonstrated that prolonged increases in the concentration of dopamine (DA) result in a time-dependent decrease in sensitivity of pDA neurons to DA, which we termed DA inhibition reversal (DIR). In this study, we used extracellular recordings to examine factors mediating DIR. A 40 min administration of DA (2.5-10 μM), but not the DA D2 receptor agonist quinpirole (50-200 nM), resulted in inhibition of neuronal firing followed by DIR. In the presence of 100 nM cocaine, inhibition followed by DIR was seen with much lower DA concentrations. Reversal of quinpirole inhibition could be induced by an activator of protein kinase C, but not of protein kinase A. Inhibitors of protein kinase C or phospholipase C blocked the development of DIR. Disruption of intracellular calcium release also prevented DIR. Reduction of extracellular calcium or inhibition of store-operated calcium entry blocked DIR, but the L-type calcium channel blocker nifedipine did not. DIR was age-dependent and not seen in pDA VTA neurons from rat pups younger than 15 days postnatally. Our data indicate that DIR is mediated by protein kinase C, and implicate a conventional protein kinase C. This characterization of DIR gives insight into the regulation of autoinhibition of pDA VTA neurons, and the resulting long-term alteration in information processing related to reward and reinforcement.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21976045      PMCID: PMC3242316          DOI: 10.1038/npp.2011.222

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  64 in total

1.  Regulation of D(1) dopamine receptors with mutations of protein kinase phosphorylation sites: attenuation of the rate of agonist-induced desensitization.

Authors:  D Jiang; D R Sibley
Journal:  Mol Pharmacol       Date:  1999-10       Impact factor: 4.436

2.  Pharmacological reduction of small conductance calcium-activated potassium current (SK) potentiates the excitatory effect of ethanol on ventral tegmental area dopamine neurons.

Authors:  M S Brodie; M A McElvain; E B Bunney; S B Appel
Journal:  J Pharmacol Exp Ther       Date:  1999-07       Impact factor: 4.030

3.  Cocaine effects in the ventral tegmental area: evidence for an indirect dopaminergic mechanism of action.

Authors:  M S Brodie; T V Dunwiddie
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-12       Impact factor: 3.000

4.  Selective inhibition of protein kinase C isozymes by the indolocarbazole Gö 6976.

Authors:  G Martiny-Baron; M G Kazanietz; H Mischak; P M Blumberg; G Kochs; H Hug; D Marmé; C Schächtele
Journal:  J Biol Chem       Date:  1993-05-05       Impact factor: 5.157

5.  Ryanodine stabilizes multiple conformational states of the skeletal muscle calcium release channel.

Authors:  E Buck; I Zimanyi; J J Abramson; I N Pessah
Journal:  J Biol Chem       Date:  1992-11-25       Impact factor: 5.157

6.  Distribution of ryanodine receptor-like immunoreactivity in mammalian central nervous system is consistent with its role in calcium-induced calcium release.

Authors:  P Sah; K Francis; E M McLachlan; P Junankar
Journal:  Neuroscience       Date:  1993-05       Impact factor: 3.590

7.  Expression and properties of two distinct classes of the phorbol ester receptor family, four conventional protein kinase C types, and a novel protein kinase C.

Authors:  Y Akita; S Ohno; Y Konno; A Yano; K Suzuki
Journal:  J Biol Chem       Date:  1990-01-05       Impact factor: 5.157

8.  Protein kinase C mediates phosphorylation, desensitization, and trafficking of the D2 dopamine receptor.

Authors:  Yoon Namkung; David R Sibley
Journal:  J Biol Chem       Date:  2004-09-03       Impact factor: 5.157

9.  The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C.

Authors:  D Toullec; P Pianetti; H Coste; P Bellevergue; T Grand-Perret; M Ajakane; V Baudet; P Boissin; E Boursier; F Loriolle
Journal:  J Biol Chem       Date:  1991-08-25       Impact factor: 5.157

10.  Ryanodine induces persistent inactivation of the Ca2+ release channel from skeletal muscle sarcoplasmic reticulum.

Authors:  I Zimányi; E Buck; J J Abramson; M M Mack; I N Pessah
Journal:  Mol Pharmacol       Date:  1992-12       Impact factor: 4.436

View more
  17 in total

1.  Anaplastic lymphoma kinase regulates binge-like drinking and dopamine receptor sensitivity in the ventral tegmental area.

Authors:  John W Dutton; Hu Chen; Chang You; Mark S Brodie; Amy W Lasek
Journal:  Addict Biol       Date:  2016-01-11       Impact factor: 4.280

2.  Calcium currents regulate dopamine autoreceptors.

Authors:  Anders Borgkvist; Eugene V Mosharov; David Sulzer
Journal:  Brain       Date:  2014-08       Impact factor: 13.501

3.  Ethanol Dependence Abolishes Monoamine and GIRK (Kir3) Channel Inhibition of Orbitofrontal Cortex Excitability.

Authors:  Sudarat Nimitvilai; Marcelo F Lopez; Patrick J Mulholland; John J Woodward
Journal:  Neuropsychopharmacology       Date:  2017-01-31       Impact factor: 7.853

4.  Effects of monoamines on the intrinsic excitability of lateral orbitofrontal cortex neurons in alcohol-dependent and non-dependent female mice.

Authors:  Sudarat Nimitvilai; Marcelo F Lopez; John J Woodward
Journal:  Neuropharmacology       Date:  2018-04-22       Impact factor: 5.250

5.  Reversal of dopamine D2 agonist-induced inhibition of ventral tegmental area neurons by Gq-linked neurotransmitters is dependent on protein kinase C, G protein-coupled receptor kinase, and dynamin.

Authors:  Sudarat Nimitvilai; Maureen A McElvain; Mark S Brodie
Journal:  J Pharmacol Exp Ther       Date:  2012-09-27       Impact factor: 4.030

6.  Anaplastic Lymphoma Kinase Regulates Internalization of the Dopamine D2 Receptor.

Authors:  Donghong He; Amy W Lasek
Journal:  Mol Pharmacol       Date:  2019-11-16       Impact factor: 4.436

7.  AMP-activated protein kinase slows D2 dopamine autoreceptor desensitization in substantia nigra neurons.

Authors:  Wei Yang; Adam C Munhall; Steven W Johnson
Journal:  Neuropharmacology       Date:  2019-07-10       Impact factor: 5.250

8.  Dopamine D2 receptor desensitization by dopamine or corticotropin releasing factor in ventral tegmental area neurons is associated with increased glutamate release.

Authors:  Sudarat Nimitvilai; Melissa Herman; Chang You; Devinder S Arora; Maureen A McElvain; Marisa Roberto; Mark S Brodie
Journal:  Neuropharmacology       Date:  2014-03-19       Impact factor: 5.250

9.  Reversal of inhibition of putative dopaminergic neurons of the ventral tegmental area: interaction of GABA(B) and D2 receptors.

Authors:  S Nimitvilai; D S Arora; M A McElvain; M S Brodie
Journal:  Neuroscience       Date:  2012-09-15       Impact factor: 3.590

10.  Reversal of dopamine-mediated firing inhibition through activation of the dopamine transporter in substantia nigra pars compacta neurons.

Authors:  Daniela Aversa; Alessandro Martini; Ezia Guatteo; Antonio Pisani; Nicola Biagio Mercuri; Nicola Berretta
Journal:  Br J Pharmacol       Date:  2018-07-23       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.